LTRN
Price
$2.97
Change
-$0.09 (-2.94%)
Updated
Feb 4, 02:58 PM (EDT)
Capitalization
33.44M
29 days until earnings call
Intraday BUY SELL Signals
RLAY
Price
$8.36
Change
-$0.32 (-3.69%)
Updated
Feb 4, 03:15 PM (EDT)
Capitalization
1.5B
15 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

LTRN vs RLAY

Header iconLTRN vs RLAY Comparison
Open Charts LTRN vs RLAYBanner chart's image
Lantern Pharma
Price$2.97
Change-$0.09 (-2.94%)
Volume$239
Capitalization33.44M
Relay Therapeutics
Price$8.36
Change-$0.32 (-3.69%)
Volume$1.3K
Capitalization1.5B
LTRN vs RLAY Comparison Chart in %
LTRN
Daily Signal:
Gain/Loss:
RLAY
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
LTRN vs. RLAY commentary
Feb 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LTRN is a Hold and RLAY is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Feb 04, 2026
Stock price -- (LTRN: $3.06 vs. RLAY: $8.67)
Brand notoriety: LTRN and RLAY are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: LTRN: 116% vs. RLAY: 263%
Market capitalization -- LTRN: $33.44M vs. RLAY: $1.5B
LTRN [@Biotechnology] is valued at $33.44M. RLAY’s [@Biotechnology] market capitalization is $1.5B. The market cap for tickers in the [@Biotechnology] industry ranges from $118.13B to $0. The average market capitalization across the [@Biotechnology] industry is $2.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LTRN’s FA Score shows that 1 FA rating(s) are green whileRLAY’s FA Score has 1 green FA rating(s).

  • LTRN’s FA Score: 1 green, 4 red.
  • RLAY’s FA Score: 1 green, 4 red.
According to our system of comparison, RLAY is a better buy in the long-term than LTRN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LTRN’s TA Score shows that 2 TA indicator(s) are bullish while RLAY’s TA Score has 5 bullish TA indicator(s).

  • LTRN’s TA Score: 2 bullish, 6 bearish.
  • RLAY’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, RLAY is a better buy in the short-term than LTRN.

Price Growth

LTRN (@Biotechnology) experienced а -7.55% price change this week, while RLAY (@Biotechnology) price change was +2.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.39%. For the same industry, the average monthly price growth was +1.48%, and the average quarterly price growth was +33.05%.

Reported Earning Dates

LTRN is expected to report earnings on Mar 05, 2026.

RLAY is expected to report earnings on Feb 19, 2026.

Industries' Descriptions

@Biotechnology (-2.39% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RLAY($1.5B) has a higher market cap than LTRN($33.4M). RLAY YTD gains are higher at: 2.482 vs. LTRN (0.990). LTRN has higher annual earnings (EBITDA): -19.65M vs. RLAY (-322.8M). RLAY has more cash in the bank: 596M vs. LTRN (12.4M). LTRN has less debt than RLAY: LTRN (94K) vs RLAY (33.3M). RLAY has higher revenues than LTRN: RLAY (8.36M) vs LTRN (0).
LTRNRLAYLTRN / RLAY
Capitalization33.4M1.5B2%
EBITDA-19.65M-322.8M6%
Gain YTD0.9902.48240%
P/E RatioN/AN/A-
Revenue08.36M-
Total Cash12.4M596M2%
Total Debt94K33.3M0%
TECHNICAL ANALYSIS
Technical Analysis
LTRNRLAY
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
87%
Momentum
ODDS (%)
Bearish Trend 2 days ago
87%
Bullish Trend 2 days ago
80%
MACD
ODDS (%)
Bearish Trend 2 days ago
86%
Bullish Trend 2 days ago
88%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
86%
Bullish Trend 2 days ago
79%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
79%
Advances
ODDS (%)
N/A
Bullish Trend 2 days ago
83%
Declines
ODDS (%)
Bearish Trend 7 days ago
85%
Bearish Trend 20 days ago
89%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
87%
View a ticker or compare two or three
Interact to see
Advertisement
LTRN
Daily Signal:
Gain/Loss:
RLAY
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
NBSRX58.151.01
+1.77%
Neuberger Quality Equity Inv
CGRCX30.150.01
+0.03%
Invesco Comstock Select C
FTHFX53.15N/A
N/A
FullerThaler Behavioral Sm-Cp Eq R6
AMGAX17.69-0.14
-0.79%
Alger Mid Cap Growth A
FLRAX43.43-0.47
-1.07%
Nuveen Large Cap Select A

LTRN and

Correlation & Price change

A.I.dvisor indicates that over the last year, LTRN has been loosely correlated with AXON. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if LTRN jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LTRN
1D Price
Change %
LTRN100%
N/A
AXON - LTRN
36%
Loosely correlated
-1.89%
ARWR - LTRN
34%
Loosely correlated
-1.18%
RLAY - LTRN
33%
Poorly correlated
+6.38%
BMRN - LTRN
33%
Poorly correlated
-0.59%
BCYC - LTRN
32%
Poorly correlated
-7.55%
More

RLAY and

Correlation & Price change

A.I.dvisor indicates that over the last year, RLAY has been loosely correlated with BDTX. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if RLAY jumps, then BDTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RLAY
1D Price
Change %
RLAY100%
+6.38%
BDTX - RLAY
55%
Loosely correlated
-0.79%
NRIX - RLAY
55%
Loosely correlated
-1.76%
IMNM - RLAY
52%
Loosely correlated
+3.18%
IMTX - RLAY
50%
Loosely correlated
-0.40%
NUVL - RLAY
50%
Loosely correlated
+2.12%
More